EpiBiotech offers a comprehensive preclinical and translational efficacy evaluation platform for hair growth and hair loss candidates, spanning compounds, biologics, and cosmetic raw materials. The service combines in vi...
Epibiotech offers a specialized in vitro and ex vivo screening platform for evaluating hair follicle and scalp health, enabling medium-throughput screening of pharmaceuticals targeting cellular senescence and aging-relat...
A novel RIPK1 inhibitor, Necrostatin-1, promotes hair growth by inhibiting necroptosis, potentially treating androgenetic alopecia and alopecia areata. Seeking partners for clinical trials.